Skip to main content
Skip to section navigation
Skip to footer
French
English
About Us
Management
Board of Directors
Scientific Advisory Board
Clinical Pipeline
GTX-104
GTX-102
GTX-101
Investor Relations
Overview
News / Events
Company Info
Financial Results
Stock Data
Regulatory Filings
Governance
Newsroom
Careers
Contact
French
Press Releases
Investor Relations
Investor Relations
Overview
News / Events
Overview
Press Releases
Media
IR Calendar
Email Alerts
Company Info
Overview
Presentations
Contacts
FAQ
Financial Results
Stock Data
NASDAQ: ACST
Analyst Coverage
Regulatory Filings
Overview
All SEC Filings
Annual Reports
Section 16 Filings
SEDAR
Tax Notifications
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
News / Events
Overview
Press Releases
Media
IR Calendar
Email Alerts
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Category
All Releases
Financial Releases
Acasti Announces Pricing of US$20 Million Offering of Units
Nov 27, 2013
Acasti Announces Proposed Offering of Units
Nov 26, 2013
Acasti Completes PK IND Submission
Nov 11, 2013
Reed V. Tuckson, M.D. Joins Acasti's Board of Directors
Nov 5, 2013
Acasti Strengthens Its IP Portfolio
Oct 29, 2013
Acasti Announces Second Quarter Results
Oct 15, 2013
Acasti Announces Positive Phase II Open Label Clinical Trial Results
Aug 13, 2013
Acasti Signs Manufacturing Agreement
Jul 31, 2013
Acasti Announces First Quarter Results
Jul 15, 2013
Acasti Reports Results of Annual and Special Meeting
Jun 28, 2013
rss_feed
News RSS
Prev
1...
18
19
20
21
22
23
24
25
26
27
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed
back-to-top